Little evidence exists to guide helicopter emergency medical services (HEMS) triage, and current practice is inefficient. The Air Medical Prehospital Triage (AMPT) score was developed to identify patients most likely to benefit from HEMS compared with ground EMS. To our knowledge, no studies have evaluated the potential effect on costs and outcomes of a more targeted HEMS triage strategy, such as the AMPT score.
T rauma is the leading cause of death for Americans younger than 47 years, costing the health care system $671 billion annually for lifetime medical and productivity loss in 2013.
1,2 Injured patients access the health care system through emergency medical services (EMS), either by ground or helicopter transport. Helicopter emergency medical services (HEMS) affords access to care for a significant proportion of the US population 3 but is a costly resource, with an average annual operating cost of $2.5 million per helicopter base and charges of $6500 to $13 000 per transport. 4, 5 In 2011,
HEMS accounted for 1% of Medicare ambulance claims but 8% of payments at $420 million. 6 While HEMS has shown survival benefits, [7] [8] [9] [10] [11] [12] [13] [14] to our knowledge, little evidence exists to guide patient selection for HEMS. 10 Many systems extrapolate existing trauma triage criteria developed to identify patients requiring trauma center care, 15 which may not be appropriate for air medical triage. Further, current practice relies on the judgment of first responders for the need of HEMS transport. High rates of unnecessary HEMS transports resulting in excess costs without health benefits have been reported. 16 A more selective HEMS triage strategy could potentially reduce health care system costs for injured patients in the United States. Our group developed the Air Medical Prehospital Triage (AMPT) score to identify patients at the scene of injury most likely to benefit from HEMS transport. 17 The AMPT score incorporates 7 criteria available at the scene that can be applied to individual patients ( Table 1) . Prior studies suggest that the AMPT score is able to discriminate between injured patients who have a survival benefit if transported by HEMS and patients who do not. 17, 18 However, to our knowledge, no data exist evaluating the costs and benefits of a more targeted HEMS triage strategy, such as the AMPT score. Therefore, our objective was to evaluate the cost-effectiveness of current triage practices compared with the AMPT score for HEMS triage of trauma patients at the scene of injury. We hypothesize the AMPT score will be more cost-effective than current HEMS triage practices.
Methods

Study Design and Model Inputs
A cost-effectiveness Markov model was developed to compare current triage practices with the AMPT score as HEMS scene triage strategies from the health care system perspective over a patient lifetime horizon. Model inputs were obtained from the National Trauma Databank (NTDB), 19 the National Study on the Costs and Outcomes of Trauma, 20 the US Centers for Medicare and Medicaid Services Ambulance Fee Schedule, 21 and published literature (eMethods 1 in the Supplement). This model was applied to a nationally representative cohort of injured patients. The model follows a patient from time of injury through transport to a trauma center by either ground EMS (GEMS) or HEMS, hospitalization, first year postinjury, and the remainder of their life, assuming no additional injury event. This study was exempt from review by the University of Pittsburgh Institutional Review Board, and informed consent was waived because data were deidentified. The primary outcome was the incremental costeffectiveness ratio (ICER), representing the cost paid by the health care system in dollars per quality-adjusted life-year (QALY) gained comparing current practice for HEMS triage with triage using the AMPT score. The ICER was calculated as the difference in cost between the 2 strategies divided by the difference in QALYs between the 2 strategies. An ICER threshold of $100 000/QALY or less was applied, which is a generally accepted value of cost-effective medical interventions in highincome countries.
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Decision Analytic Markov Model
A decision analytic tree model was developed with a decision point choosing either current practice or the AMPT score as a triage strategy (Figure 1) . Patients evaluated at the hospital then entered the Markov model. Patients could enter the model through 2 health states, the first representing patients who were discharged alive from the hospital and the second representing patients who died during hospitalization. Surviving patients either died within 1 year of injury or survived the first 
Key Points
Question Is a selective triage strategy more cost-effective than current practices for determining which injured patients should be transported by helicopter vs ground ambulance to a trauma center?
Findings In a nationally representative cohort using cost-effectiveness modeling, current helicopter triage practices have an incremental cost-effectiveness ratio of $255 333 per quality-adjusted life-year compared with using the Air Medical Prehospital Triage score, which is significantly more than the generally accepted threshold of $100 000 per quality-adjusted life-year for cost-effective medical interventions.
Meaning Current helicopter triage practices are not cost-effective compared with the Air Medical Prehospital Triage score for determining helicopter vs ground transport for trauma patients. 
Model Assumptions
Decision tree branch points were populated with the probability of discrete mutually exclusive events ( Table 2) . Triage strategies were modeled as probability of HEMS or GEMS transport. For the AMPT score triage strategy, the AMPT score was applied to the national NTDB cohort to derive a triage allocation to either HEMS or GEMS irrespective of the patient's actual transport mode. For the current practice triage strategy, the proportion of patients actually undergoing HEMS or GEMS transport was input as the probability of triage to HEMS and GEMS transport. Fatal crash risk was modeled as the probability of a fatal crash per mile traveled for HEMS and GEMS (eMethods 2 in the Supplement).
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For patients evaluated at the hospital, the probability of survival in the NTDB was used to model patient entry into the Markov model as either discharged alive or dead. Patients transported by GEMS in the model were divided between these 2 health states based on the probability of survival in the NTDB for patients actually transported by GEMS.
For patients transported by HEMS under the current triage strategy, a risk-adjusted odds ratio for survival of HEMS compared with GEMS transport was obtained from a multilevel random coefficient logistic regression model incorporating fixed effects for demographic characteristics, mechanism, vital signs, injury severity, and trauma center level while accounting for center-level clustering (eMethods 3 in the Supplement). This risk-adjusted odds ratio was then converted to an absolute increase in survival to obtain the probability of survival for patients transported by HEMS under the current practice strategy. 33 For patients transported by HEMS under the AMPT score strategy, the same methods were applied to obtain a risk-adjusted odds ratio and absolute increase in survival for HEMS. The resulting probabilities of survival are shown in Table 2 . The probability of mortality within 1 year of injury after being discharged alive was obtained from MacKenzie et al. 29 Annual probability of mortality after 1 year postinjury was obtained from US life tables, inflated for higher mortality after severe injury observed compared with the general population. 30, 34 A base case was estimated using national patient characteristics from the NTDB and literature (Table 2 ). Base case inputs included mean patient age, mean length of hospitalization, and mean transport distance. Mean transport distance in miles was estimated assuming average speed of 120 mph from transport time for HEMS transports. The Markov cycle length was set to 1 year, and a 3% discount rate was applied to costs and QALYs.
32
Costs Costs in the model include transport costs, hospitalization costs, cost of health care in the first year postinjury, and annual health care costs after the first year postinjury ( Table 2 ). All costs were adjusted to 2015 US dollars using the Consumer Price Index. 35 All economic inputs represent estimated costs, expenditures, or reimbursements rather than charges. Transport costs were based on the Centers for Medicare and Medicaid Services Ambulance Fee Schedule (eMethods 4 in the Supplement). 21 Hospitalization costs were estimated as a factor of 1.45 for patients with severe injury to account for the nearly 50% increase in health service utilization costs compared with a noninjured population (eMethods 5 in the Supplement). 4, 36 Total lifetime patient costs were calculated as the sum of transport, hospitalization, 1-year health care costs, and annual postinjury health care costs.
Costs to the health care system were also included in the event of a fatal crash ( Table 2 ). The cost of replacing a ground ambulance was obtained from a representative manufacturer website. 27 The cost of replacing a helicopter was estimated from helicopter manufactures based on the 3 most common helicopter models used for HEMS in the United States.
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Health Outcomes
Health outcomes were evaluated as health state utilities in the form of QALYs. Utilities for hospitalization, discharge alive, 1 year postinjury, and annually were accounted for in the model (Table 2 ). Utility at discharge 4 and 1 year postinjury 26 were obtained from literature. After the first year of injury, utility annually declines with age and was estimated by the median Health and Activity Limitation Index by age. 31 These utilities were decreased by 30% to reflect a lower baseline utility after surviving severe injury. 26 Finally, loss in QALYs to the health care system were estimated for the loss of ambulance or helicopter crews in the event of a fatal crash from Delgado et al. 4 
Sensitivity Analyses
Several sensitivity analyses were performed to evaluate the robustness of results to model assumptions. The first was a structural sensitivity analysis that altered the model to assume 20.46% of patients were severely injured based on the overall proportion of patients in the NTDB with an Injury Severity Score (ISS) greater than 15. Further, it was assumed only these severely injured patients have a survival benefit from HEMS transport. Thus, the same probability of survival was assigned to patients with an ISS of 15 or less transported by either HEMS or GEMS. These changes in probabilities, costs, and utilities were modeled as weighted averages for patients with an ISS greater than 15 and those with an ISS of 15 or less (eMethods 6 in the Supplement). This sensitivity analysis is based on the overall proportion of patients with an ISS greater than 15 and assumes the same distribution of patients with an ISS greater than 15 across HEMS and GEMS transport in both triage strategies. Because there is some patient selection occurring under both strategies, this assumption may not accurately reflect the distribution of ISS across transport modes and triage strategies. To further explore this, the model was revised to reflect the actual distribution of ISSs greater than 15 in the NTDB for each transport mode under each triage strategy.
One-way sensitivity analysis was performed across model variables. The most influential variables were selected for 2-way sensitivity analysis to evaluate the effect of varying both inputs simultaneously. Finally, probabilistic sensitivity analysis was performed using 10 000 Monte Carlo simulations (eMethods 7 in the Supplement). A cost-effectiveness acceptability curve was generated to evaluate the proportion of Monte Carlo iterations that are cost-effective under each HEMS triage strategy across a range of ICER threshold values. Stata version 13MP (StataCorp) was used for statistical analysis, and TreeAgePro version 2014 (TreeAge Software) was used for costeffectiveness modeling.
Results
The base case demonstrated higher cost and slightly higher effectiveness for current practice compared with the AMPT score. This results in an ICER of $255 333/QALY for current practice compared with the AMPT score ( Table 3) . Under the assumption that 20% of patients had an ISS greater than 15 and that a survival benefit for HEMS transport occurs only in these patients, current practice had an ICER of $176 686/QALY compared with the AMPT score as triage strategies. The actual proportion of patients with an ISS greater than 15 across transport modes in the current practice strategy demonstrated 40.79% of patients transported by HEMS and 16.87% of patients transported by GEMS had an ISS greater than 15. In the AMPT score strategy, 80.06% of patients transported by HEMS and 13.38% of patients transported by GEMS had an ISS greater than 15. Analysis under the actual distribution of severely injured patients across transport modes demonstrated current practice was more expensive and less effective, resulting in this strategy being dominated by the AMPT score strategy (Table 3) .
One-way sensitivity analysis demonstrated that the probability of HEMS transport, probability of survival for HEMS transport, and cost of HEMS transport were the most influential model inputs (eFigure 1 in the Supplement). Two-way sensitivity analysis of the probability of HEMS transport under both strategies revealed that for current practice to be costeffective, the AMPT score would need to have a probability of HEMS transport 5% higher than current practice (eFigure 2 in the Supplement). Two-way sensitivity analysis of the probability of survival for HEMS transport under both strategies revealed that the AMPT score remained the cost-effective strategy until the mortality rate of patients transported by HEMS using the AMPT score was more than 2% higher than mortality of patients transported by HEMS under current practice (eFigure 3 in the Supplement). Probabilistic sensitivity analysis revealed that the AMPT score strategy is the cost-effective strategy in 85% of iterations at the $100 000/QALY threshold (eFigure 4 in the Supplement). Current practice as a HEMS triage strategy does not achieve the majority (greater than 50%) of cost-effective iterations until the ICER is greater than $310 000/QALY (Figure 2 ).
Discussion
To our knowledge, this is the first study to evaluate the costeffectiveness of triage strategies for HEMS transport of injured patients. Our results demonstrate that the cost per QALY gained using current HEMS triage practices is more than 2.5-fold greater than generally accepted cost-effectiveness thresholds in the United States compared with the AMPT score. When assuming only severely injured patients benefit from HEMS, current triage practices are still not cost-effective. Further, when using the actual distribution of severely injured patients across transport modes in each triage strategy, current practice was both costlier and less effective than the AMPT score.
Sensitivity analyses were performed to ensure our results were robust to changes in model assumptions across a range of clinically plausible values. To achieve costeffectiveness of current triage practices, the AMPT score would have to assign at least 5% more patients to HEMS transport than current practice. Because the AMPT score is a more selective triage strategy, this is unlikely.
The AMPT score remained the cost-effective triage strategy until the risk-adjusted mortality for patients transported by HEMS was at least 2% greater than current practice. Because the AMPT score was developed to identify patients most likely to have a survival benefit from HEMS, current practice is unlikely to have a lower mortality rate. Further, we used a conservative estimate of the AMPT score treatment effect, ignoring patients that should have gone by HEMS but were transported by GEMS with high risk of death. Including these patients suggests an even higher survival benefit for the AMPT score.
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Probabilistic sensitivity analysis suggested current triage practices did not become cost-effective until the costeffectiveness threshold is greater than $310 000/QALY, more than 3-fold the generally accepted cost-effectiveness threshold. Even if using more liberal cost-effectiveness ICER thresholds of $150 000/QALY to $200 000/QALY, as suggested by some for intervention in the United States, 23 our results suggest the AMPT score strategy would be favored over current practice.
Helicopter emergency medical services triage strategy has significant potential implications for the US health care system. Helicopter emergency medical services have expanded significantly in the United States over the last decade, and studies report high rates of unnecessary use and overtriage among patients transported by HEMS. [8] [9] [10] [11] [12] 38 This aligns with our findings suggesting current HEMS triage practices result in high costs, as many patients are transported by helicopter with marginal improvements in outcomes. The economic effect to the health care system of potentially unnecessary transports is not trivial. Charges can range between $6500 and $13 000 per transport to cover annual operating costs between $2.2 and $2.7 million per helicopter base for aircraft maintenance, fuel, equipment, and personnel required for around-the-clock response readiness. 4 A 2011 Centers for Medicare and Medicaid Services report demonstrated $5.3 billion was spent on medical transport, with HEMS claims resulting in 15-fold higher payment per transport than GEMS claims. 6 This study has policy implications for the US health care system, given the mortality, morbidity, and economic burden of trauma in the United States.
1,2 Rising HEMS charges and unnecessary transports are increasing. 39, 40 As focus shifts toward cost-effective care in the United States, the AMPT score represents a potential source of cost savings to the US health care system without reducing the quality of care delivered. This is achieved by reducing the number of HEMS transports for which there is low likelihood of survival benefit to the patient using simple criteria available in the field. Further, the AMPT is not simply a restrictive strategy but identifies patients most likely to benefit from HEMS transport and may reduce undertriage as well. 18 Thus, to our knowledge, the AMPT Cost-effectiveness acceptability curve across a range of cost-effectiveness thresholds from probabilistic sensitivity analysis. The Air Medical Prehospital Triage (AMPT) score is cost-effective in 85% of iterations at $100 000 per quality-adjusted life-year, while current practice only has more cost-effective iterations when the cost-effectiveness threshold is greater than $310 000 per quality-adjusted life-year. All costs were adjusted to 2015 US dollars using the Consumer Price Index. 35 score represents the first evidence-based air medical triage tool available. Local and regional trauma systems should consider integrating the AMPT score into air medical triage protocols. Further, there may be payer implications, as the AMPT score may form a starting point for evidence-based reimbursement of HEMS charges.
Limitations
This study has several limitations. First, cost-effectiveness models require parameter inputs derived from existing data and literature. This requires many assumptions, and the results are specific to these data and assumptions. The data used for model inputs came from a variety of sources across varied populations and time periods, assuming each is representative of national trauma patients. Survival benefits were assumed at a binary ISS threshold; however, there are likely diminishing benefits at extreme levels of injury. Model inputs derived from literature were not specific to patients transported by HEMS or GEMS for utility and QALYs. Utilities were deflated 30% annually to reflect lower quality of life after severe injury; however, this was applied uniformly across patients and time, which may not reflect true utility for specific types of injury or over long periods of time. Further, several inputs were derived empirically from NTDB data using observational analysis methods and are subject to potential unobserved confounding. We did perform several sensitivity analyses to evaluate the robustness of our conclusions to variations in these data and assumptions, which demonstrated similar results.
The AMPT score is based on patient-level characteristics identified in the field. Application of the score was based on NTDB anatomic diagnoses, and it is unclear if these specific injuries were identified by EMS personnel in the field. Further, the AMPT score does not account for local geography and distance to the trauma center. Some patients under current triage practices may have been triaged to HEMS transport from rural areas with long distances to the closest trauma center rather than because of patient condition. Rural areas may use HEMS transport for less injured patients as long-distance transport by GEMS may leave the region without EMS resources for prolonged periods. Adverse weather can preclude HEMS transport for safety reasons, resulting in triage misclassification under current practices. These logistical considerations will vary by individual trauma system and need to be addressed on a regional level. Thus, the AMPT score is not intended for use in isolation but in conjunction with individual system factors for air medical triage protocols.
Conclusions
Current triage practices are not cost-effective compared with the AMPT score for HEMS triage. The AMPT score was the preferred triage strategy across a range of scenarios, indicating robustness of our results. The AMPT score identifies patients most likely to benefit from HEMS transport while potentially reducing costs to the US health care system. Given the significant health and economic effect of injury in the United States, the AMPT score should be considered when developing air medical transport protocols for trauma patients.
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Moving Toward a Clinically and Fiscally Sound Aeromedical Triage System for Trauma Heena P. Santry, MD, MS; Stacy B. Sanders, MD Serious, potentially life-threatening injury mandates expeditious emergency medical services (EMS) transportation to the hospital for urgent evaluation and stabilization. Transporting patients via helicopter EMS (HEMS) offers several obvious advantages vs ground transportation with regard to speed and access; however, these advantages are associated with significant cost. 1 In this context, proper identification of prehospital patients who would benefit most from helicopter transport is both clinically and fiscally significant. Unfortunately, evidence suggests that first responders are often inaccurate in this determination. 2 Thus, the mortality benefit and cost-effectiveness for HEMS remains controversial among trauma clinicians. 3 In this issue of JAMA Surgery, Brown et al 4 bring additional focus to this debate. The authors had previously validated a score, the Air Medical Prehospital Triage score, which minimizes first responder bias in interpretation of scene and patient data. 5 In this study, the authors apply a sophisticated cost-effectiveness analysis to compare the Air Medical Prehospital Triage score with standard field triage. Importantly, the authors not only consider early mortality, as all previous studies have, but also incorporate long-term survival, quality of life, and risk of fatal crash during transport. They conclude that using standard triage practices to request HEMS is at least 2.5-fold more costly than using the Air Medical Prehospital Triage score. At a time when reducing unnecessary costs in our health care system is paramount, the policy implications of this
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For helicopter transport the rate of fatal crashes per 100,000 flight hours from 2000 to 2005 1 (Table 1) was averaged giving a fatal accident rate of 1.8833 fatal crashes per 100,000 flight hours. To convert flight hours to miles traveled, an average flight speed of 120 miles per hour was multiplied by 100,000 flight hours to give 12,000,000 miles traveled as the equivalent of 100,000 flight hours. The averaged fatal accident rate of 1.8833 was then divided by 12,000,000 miles to obtain the fatal crash rate per mile traveled of 0.0000001569, or 1.6x10 -7 . This fatal crash rate was then multiplied by the transport distance to obtain the probability of a fatal crash for any given helicopter transport. This results in a probability of 8.6x10 -6 for fatal crash in the base-case of a 55mile helicopter transport. For ground ambulance transport, a rate of 7.7 fatal crashes per 100,000,000 miles traveled has been reported, although may vary widely given the absence of systematic collection of ambulance fatal crash data. 2 This was converted a fatal crash rate of 0.000000077 per mile traveled, or 0.8x10 -7 . This fatal crash rate was then multiplied by the transport distance to obtain the probability of a fatal crash for any given ground ambulance transport. This results in a probability of 4.2x10 -6 for fatal crash in the base-case of a 55mile ground ambulance transport. eMethods 3. Risk adjustment models and conversion of adjusted odds ratios to probability of survival
To determine the probability of survival for patients transported by helicopter emergency medical services (HEMS) under the current triage strategy, a risk-adjusted odds ratio for survival of HEMS compared to ground emergency medical services (GEMS) transport was obtained from a multilevel logistic regression model in patients actually undergoing HEMS transport or GEMS transport with transport time >15minutes to capture GEMS patients with the possibility of undergoing HEMS transport. This random coefficient model adjusted for age, sex, race, insurance, mechanism, prehospital vital signs, injury severity score (ISS), Trauma Mortality Prediction Model (TMPM) predicted mortality, 3 and trauma center level while including a random effect for centers to account for clustering and accounting for the possibility that the effect of HEMS transport on survival was different across different centers. An unstructured covariance structure was used for the random effects. A total of 838 centers (clusters) were included as random effects. The fixed effects portion of the model demonstrated a c-statistic of 0.93, indicating excellent discrimination, and had a Pearson Chi-square goodness-of-fit test p>0.999 indicating adequate calibration. Pearson residuals and empirical Bayes means of the random effects both demonstrated approximate normal distributions, upholding model assumptions.
To determine probability of survival for patients transported by HEMS under the AMPT score strategy, the same model described above was applied to only patients that had a concurrent AMPT score triage assignment and actual transport mode (i.e. AMPT assigned to HEMS and actual HEMS transport or AMPT assigned to GEMS and actual GEMS transport), again restricting GEMS patients to transport time >15minutes. This was done to produce the most conservative treatment-effect estimates for HEMS transport, as including patients that should have been transported by HEMS according to the AMPT score but were actually transported by GEMS may have high mortality and increase the apparent survival benefit of patients transported by HEMS when triaged to HEMS by the AMPT score.
Adjusted odds ratios (AOR) obtained from the random coefficient multilevel logistic regression models were applied to the NTDB for the treatment-effect of HEMS compared to GEMS. These AOR were then converted to a number need to treat using the following formula: 4 
NNT = ((CER*(AOR-1))+1)/(CER*(AOR-1)*(1-CER))
NNT, number needed to treat; CER, control event rate; AOR, adjusted odds ratio The control event rate was set as the probability of survival in the GEMS group. The absolute change in probability of survival for HEMS transport was determined using the following formula:
Absolute risk change = 1/NNT The absolute risk change was then added to the probability of survival in the GEMS group to obtain the probability of survival for the HEMS group.
For the base-case, an AOR of 1.08 (95%CI 1.01-1.17, p=0.03) for current practice and 1.11 (95%CI 1.02-1.22, p=0.02) for the AMPT score were obtained. This results in NNT of 278 and 218 respectively, with absolute risk changes of 0.0036 and 0.0046 respectively. Applied to the GEMS probability of survival of 0.9520, the probability of survival for HEMS under current practice is 0.9556, and under the AMPT score is 0.9566.
For the ISS structural sensitivity analyses, an AOR of 1.17 (95%CI 1.10-1.26, p<0.01) for current practice and 1.20 (95%CI 1.09-1.31, p<0.01) for the AMPT score were obtained in patients with an ISS>15. This results in NNT of 52 and 45 respectively, with absolute risk changes of 0.0193 and 0.0222 respectively. Applied to the GEMS probability of survival of 0.8467, the probability of survival for HEMS in patients with ISS>15 under current practice is 0.8660, and under the AMPT score is 0.8689.
. eMethods 4. Calculation of transport costs
Transport service charges were based on the Centers for Medicare and Medicaid Services (CMS) ambulance fee schedule. 5 For ground ambulance cost, the level of service and rurality were taken into account. The service levels considered were advanced life support (ALS) 1 -emergency, defined as any intervention applied under local protocols by an emergency medical technician-intermediate or paramedic in the context of an emergency response, and ALS 2, defined as administration of at least 3 intravenous boluses of medication or crystalloid, continuous intravenous infusion of medication or crystalloid, or any of the following procedures: manual defibrillation/cardioversion, endotracheal intubation, central venous line placement, cardiac pacing, chest decompression, surgical airway, or intraosseous line placement.
The National Emergency Medical Services Information Systems (NEMSIS) dataset is a national database containing information for EMS responses. 6 Data from 2012 constituting data from 37 states was used to evaluate the proportion of scene responses for trauma billing at the ALS 1-emergency or ALS 2 level of service. NEMSIS data was also used to determine the proportion of scene trauma transports coming from rural or super-rural (lowest 25 th percentile of population density) zip codes based on CMS definitions. Only ALS services and rural/superrural locations were considered, as patients from urban settings or only requiring basic life support would not likely require HEMS transport.
Charges for ground ambulance transport are calculated using a base charge plus mileage charge, with bonuses for higher level of service and more rural location. Additionally, a higher mileage charge is applied to the first seventeen rural transport miles. A weighted average base charge was calculated using the proportion of scene trauma calls with ALS 1-emergency or ALS 2 level of service and rural or super-rural location. The weighted base charge was added to the mileage charge based on the transport distance. Finally, the transport distance for GEMS was multiplied by a coefficient of 1.3, to reflect the equivalent driving distance compared to straight line flight distance a helicopter would take. 7 The final formula for GEMS transport cost using logic operators to account for different mileage charges over the first seventeen miles was as follows: Probabilistic sensitivity analysis was performed using 10,000 second-order Monte Carlo simulation trials. For each trial, all model input values below were randomly selected from the distribution in Table 5 with indicated distribution parameters to evaluate cost-effectiveness under those conditions, reflecting the uncertainty in each model input value. Blue area represent pairs of these values were the AMPT strategy is more cost-effective and red area represent pairs of these values were the current practice strategy is more cost-effective. Black arrow demonstrates that for current practice to be the cost-effective strategy, the AMPT score would have to have to have a probability of HEMS transport more than 5% greater than current practice (i.e. the AMPT strategy would have to triage 17.5% of patients to HEMS transport while current practice only triaged 12.5% of patients to HEMS transport). eFigure 3. Two-way sensitivity analysis of probability of survival for helicopter emergency medical services (HEMS) transport under the Air Medical Prehospital Triage (AMPT) score triage strategy (psurvivalHEMS_AMPT) and probability of survival for HEMS transport under the current practice triage strategy (psurvivalHEMS_SOC)
Blue area represent pairs of these values were the AMPT strategy is more cost-effective and red area represent pairs of these values were the current practice strategy is more cost-effective. Black arrow demonstrates that the AMPT score remains the most cost-effective strategy until mortality of HEMS patients using the AMPT score was more than 2% greater than the mortality of HEMS patient under current practice (i.e. the AMPT strategy HEMS patient mortality of 8% with a current practice HEMS patient mortality of 6%).
